This independent HPLC lab test confirms Retatrutide 60mg from BleauGenics tested as a 2-vial set. Analysis by Janoshik Labs on May 2, 2025 showed individual vial quantities of 66.83mg and 65.61mg with purities of 99.573% and 99.419% respectively.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its effects on metabolic regulation, weight management, and glycemic control. The high purity levels across both vials indicate excellent synthesis quality with minimal contamination.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.